145 related articles for article (PubMed ID: 14987347)
1. Study of protein C, protein S, and antithrombin III in hypoxic newborns.
El Beshlawy A; Hussein HA; Abou-Elew HH; Abdel Kader MS
Pediatr Crit Care Med; 2004 Mar; 5(2):163-6. PubMed ID: 14987347
[TBL] [Abstract][Full Text] [Related]
2. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
[TBL] [Abstract][Full Text] [Related]
3. Is it time to revisit a role for antithrombotic therapy in asphyxia neonatorum?
Clark R; Carcillo JA
Pediatr Crit Care Med; 2004 Mar; 5(2):198-9. PubMed ID: 15080111
[No Abstract] [Full Text] [Related]
4. Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?
Hsin Shieh H; Roseli Barreira E; Freitas Góes P; Bousso A; Ventura Brazilian GA; Melo AM; Ibidi SM
Pediatr Crit Care Med; 2010 Nov; 11(6):767-8; author reply 768-9. PubMed ID: 21057275
[No Abstract] [Full Text] [Related]
5. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
6. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
7. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
[TBL] [Abstract][Full Text] [Related]
8. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
9. [Levels of antithrombin III and proteins C in the newborn infant].
Abad A; Marco Vera P; Mompel A; García Pérez A
Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in neonates with perinatal asphyxia.
Aly H; Hassanein S; Nada A; Mohamed MH; Atef SH; Atiea W
Brain Dev; 2009 Sep; 31(8):600-4. PubMed ID: 18926648
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between brainstem auditory evoked potential and serum neuron-specific enolase in neonates with asphyxia].
Yang JC; Zhu XL; Li HZ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):697-700. PubMed ID: 19102832
[TBL] [Abstract][Full Text] [Related]
12. [Protein C, protein S and antithrombin III at normal delivery and during abruptio placentae].
Thiam D; Diop S; Ba Gueye M; Fall K; Toure AO; Diadhiou F; Diakhate L
Dakar Med; 1999; 44(1):54-7. PubMed ID: 10797988
[TBL] [Abstract][Full Text] [Related]
13. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation.
Owings JT; Gosselin R
Semin Thromb Hemost; 1997; 23 Suppl 1():17-24. PubMed ID: 9156418
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
[TBL] [Abstract][Full Text] [Related]
15. [Birth asphyxia, neonatal risk factors for hypoxic ischemic encephalopathy].
Pálsdóttir K; Thórkelsson T; Hardardóttir H; Dagbjartsson A
Laeknabladid; 2007 Oct; 93(10):669-73. PubMed ID: 17909277
[TBL] [Abstract][Full Text] [Related]
16. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
17. Cerebral function monitoring in neonates with perinatal asphyxia--preliminary results.
Lukásková J; Tomsíková Z; Kokstein Z
Neuro Endocrinol Lett; 2008 Aug; 29(4):522-8. PubMed ID: 18766163
[TBL] [Abstract][Full Text] [Related]
18. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
Kazama Y; Takahashi K; Oguma Y; Sakuragawa N
Rinsho Ketsueki; 1988 Mar; 29(3):344-8. PubMed ID: 3398266
[No Abstract] [Full Text] [Related]
19. Activated protein C resistance in cord blood from healthy and complicated newborns.
Gursel T; Kocak U; Kaya Z; Bukulmez A; Atalay Y
J Matern Fetal Neonatal Med; 2007 Nov; 20(11):797-801. PubMed ID: 17853185
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy.
Singh D; Kumar P; Narang A
J Matern Fetal Neonatal Med; 2005 Dec; 18(6):391-5. PubMed ID: 16390805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
